Skip to main content
SpringerLink
Log in

Vitamin D receptor gene polymorphisms and the risk of Parkinson’s disease

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The effect of vitamin D receptor (VDR) gene polymorphisms on Parkinson’s disease (PD) has recently gained interest. However, evidence on this relationship is controversial. We searched PubMed, EMBASE and the Cochrane Library database targeted all studies that evaluated VDR gene polymorphisms and PD up to April 2,014. A meta-analysis was conducted on the association between VDR ApaI, BsmI, TaqI and FokI polymorphisms and PD using (1) allelic contrast, (2) dominant, (3) recessive, and (4) additive models. A total of five relevant studies involving PD patients (n = 1,266) and controls (n = 1,649) were included in the analysis. There was a significant association between FokI polymorphism and PD. In the pooled allelic analysis, the F allele was associated with increased risk of PD (OR 1.41, 95 % CI 1.14–1.75). In the genotype analysis, FF + Ff versus ff showed a significant association with PD in the dominant model (OR 2.32, 95 % CI 1.49–3.61, P = 0.0002). FF versus ff showed a significant association with PD in the additive model (OR 2.45, 95 % CI 1.52–3.93, P = 0.0002). There was also a statistically significant association between VDR BsmI polymorphisms in the recessive model, BB versus Bb + bb showed a significant increased risk of PD (OR 1.37, 95 % CI 1.01–1.87, P = 0.04). No significant associations were observed between VDR ApaI and TaqI polymorphisms and PD. To sum up, VDR BsmI and FokI polymorphisms were associated with increased risk of PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Thomas B, Beal MF (2007) Parkinson’s disease. Hum Mol Genet 16(2):R183–R194

    Article  CAS  PubMed  Google Scholar 

  2. Hancock DB, Martin ER, Vance JM, Scott WK (2008) Nitric oxide synthase genes and their interactions with environmental factors in Parkinson’s disease. Neurogenetics 9(4):249–262

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Liu GJ, Feng RN, Luo C, Bi S (2010) Lack of association between interleukin-1 alpha, beta polymorphisms and Parkinson’s disease. Neurosci Lett 480(2):158–161

    Article  CAS  PubMed  Google Scholar 

  4. McCulloch CC, Kay DM, Factor SA, Samii A, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Montimurro JS et al (2008) Exploring gene-environment interactions in Parkinson’s disease. Hum Genet 123(3):257–265

    Article  CAS  PubMed  Google Scholar 

  5. Mizuta I, Tsunoda T, Satake W, Nakabayashi Y, Watanabe M, Takeda A, Hasegawa K, Nakashima K, Yamamoto M, Hattori N et al (2008) Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson’s disease. Hum Genet 124(1):89–94

    Article  CAS  PubMed  Google Scholar 

  6. van der Walt JM, Noureddine MA, Kittappa R, Hauser MA, Scott WK, McKay R, Zhang F, Stajich JM, Fujiwara K, Scott BL et al (2004) Martin, Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am J Hum Genet 74(6):1121–1127

    Article  PubMed Central  PubMed  Google Scholar 

  7. Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V (2008) Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 65(10):1348–1352

    Article  PubMed Central  PubMed  Google Scholar 

  8. Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Sääksjärvi K, Heliövaara M (2010) Serum vitamin D and the risk of Parkinson disease. Arch Neurol 67(7):808–811

    Article  PubMed Central  PubMed  Google Scholar 

  9. Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert JW, Hupperts R, Damoiseaux J (2009) The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 8(7):621–626

    Article  CAS  PubMed  Google Scholar 

  10. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13(3):100–105

    Article  CAS  PubMed  Google Scholar 

  11. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29(1):21–30

    Article  CAS  PubMed  Google Scholar 

  12. Lambrinoudaki I, Patikas E, Kaparos G, Armeni E, Rizos D, Thoda P, Alexandrou A, Antoniou A, Tsivgoulis G, Gatzonis S et al (2013) Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study. Neurol Sci 34(8):1433–1439

    Article  PubMed  Google Scholar 

  13. Wang L, Hara K, Van Baaren JM, Price JC, Beecham GW, Gallins PJ, Whitehead PL, Wang G, Lu C, Slifer MA et al (2012) Vitamin D receptor and Alzheimer’s disease: a genetic and functional study. Neurobiol Aging 33(8):1844.e1–1844.e9

    Article  CAS  Google Scholar 

  14. Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, Vance JM, Wang L (2011) Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet 75(2):201–210

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Lv Z, Tang B, Sun Q, Yan X, Guo J (2013) Association study between vitamin d receptor gene polymorphisms and patients with Parkinson disease in Chinese Han population. Int J Neurosci 123(1):60–64

    Article  CAS  PubMed  Google Scholar 

  16. Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, Urashima M (2013) Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr 97(5):1004–1013

    Article  CAS  PubMed  Google Scholar 

  17. Zhang ZT, He YC, Ma XJ, Li DY, Lu GC (2014) Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson’s disease : a meta-analysis. Neurosci Lett 578(2):122–127

    Article  CAS  PubMed  Google Scholar 

  18. Lee YH, Kim JH, Song GG (2014) Vitamin D receptor polymorphisms and susceptibility to Parkinson’s disease and Alzheimer’s disease: a meta-analysis. Neurol Sci. doi:10.1007/s10072-014-1868-4 [Epub ahead of print]

    Google Scholar 

  19. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta- analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012

    Article  CAS  PubMed  Google Scholar 

  20. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442

    Article  CAS  PubMed  Google Scholar 

  21. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170

    Article  PubMed  Google Scholar 

  22. Duckitt K, Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330(7491):565

    Article  PubMed Central  PubMed  Google Scholar 

  23. Han X, Xue L, Li Y, Chen B, Xie A (2012) Vitamin D receptor gene polymorphism and its association with Parkinson’s disease in Chinese Han population. Neurosci Lett 525(1):29–33

    Article  CAS  PubMed  Google Scholar 

  24. Kim JS, Kim YI, Song C, Yoon I, Park JW, Choi YB, Kim HT, Lee KS (2005) Association of vitamin D receptor gene polymorphism and Parkinson’s disease in Koreans. J Korean Med Sci 20(3):495–498

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Lin CH, Chen KH, Chen ML, Lin HI, Wu RM (2014) Vitamin D receptor genetic variants and Parkinson’s disease in a Taiwanese population. Neurobiol Aging 35(5):1212.e11–1212.e13

    Article  CAS  Google Scholar 

  26. Petersen MS, Bech S, Christiansen DH, Schmedes AV, Halling J (2014) The role of vitamin D levels and vitamin D receptor polymorphism on Parkinson’s disease in the Faroe Islands. Neurosci Lett 561:74–79

    Article  CAS  PubMed  Google Scholar 

  27. Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Kawasaki K, Noya M, Takahashi D, Urashima M (2012) 25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson’s disease. Mov Disord 27(2):264–271

    Article  CAS  PubMed  Google Scholar 

  28. Török R, Török N, Szalardy L, Plangar I, Szolnoki Z, Somogyvari F, Vecsei L, Klivenyi P (2013) Association of vitamin D receptor gene polymorphisms and Parkinson’s disease in Hungarians. Neurosci Lett 551:70–74

    Article  PubMed  Google Scholar 

  29. Allen PJ, Feigin A (2014) Gene-based therapies in Parkinson’s Disease. Neurotherapeutics 11(1):60–67

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Deluca HF, Cantorna MT (2001) Vitamin D: its role and uses in immunology. FASEB J 15(14):2579–2585Ref. 30

    Article  CAS  PubMed  Google Scholar 

  31. Fang Y, van Meurs JB, d’Alesio A, Jhamai M, Zhao H, Rivadeneira F, Hofman A, van Leeuwen JP, Jehan F, Pols HA et al (2005) Promoter and 3′-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study. Am J Hum Genet 77(5):807–823

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA et al (2000) the polymorphic n terminus in human vitamin d receptor isoforms influences transcriptional activity by modulating interaction with transcription factor iib. Mol Endocrinol 14(3):401–420

    Article  CAS  PubMed  Google Scholar 

  33. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338(2):143–156

    Article  CAS  PubMed  Google Scholar 

  34. Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR (2001) Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord 2(2):203–216

    Article  CAS  PubMed  Google Scholar 

  35. Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32:S125–S127

    Article  PubMed  Google Scholar 

  36. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42(6):1142–1146

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Harbin Special Funds for Research of Scientific and Technological Innovative Talents (No. 2011RFQYS092) and Innovative Foundation of the Harbin Medical University (HCXS2010014). The following authors contributed substantially to conception and design (SB, HPQ, SRD, CLL), data collection (SB, CLL, HPQ, LW, XXF, SRD), and analyses and interpretation of data (SB, SQW, CLL, HPQ, LW, XXF, SRD). All authors revised the paper critically for important intellectual content and gave final approval of the version to be published.

Conflict of interest

The authors report no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Rehabilitation, The First Affiliated Hospital, Harbin Medical University, 150001, Harbin, China

    Chunlei Li

  2. Department of Neurology, The Fourth Affiliated Hospital, Harbin Medical University, 150001, Harbin, China

    Huiping Qi

  3. Saint-Justine Research Center, University of Montreal, Montreal, Canada

    Shuqin Wei

  4. Department of Neurology, The First Affiliated Hospital, Harbin Medical University, 150001, Harbin, China

    Le Wang, Xiaoxue Fan, Shurong Duan & Sheng Bi

Authors
  1. Chunlei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huiping Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuqin Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Le Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaoxue Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shurong Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sheng Bi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sheng Bi.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 64 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, C., Qi, H., Wei, S. et al. Vitamin D receptor gene polymorphisms and the risk of Parkinson’s disease. Neurol Sci 36, 247–255 (2015). https://doi.org/10.1007/s10072-014-1928-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1928-9

Keywords

Search

Navigation